Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.95
Enovis CORP incurred convertible notes of $460 million with UBS Securities LLC and J.P. Morgan Securities LLC at 3.875% per year maturing October 15, 2028.
- Instrument
- convertible notes
- Principal
- $460 million
- Counterparty
- UBS Securities LLC and J.P. Morgan Securities LLC
- Rate
- 3.875% per year
- Maturity
- October 15, 2028
- Event
- incurrence
Exact text from the filing
On October 24, 2023, Enovis Corporation, a Delaware corporation (the “Company”) sold to UBS Securities LLC and J.P. Morgan Securities LLC, as representatives (the “Representatives”) of the several initial purchasers (the “Initial Purchasers”), and the Initial Purchasers purchased from the Company, $460 million aggregate principal amount of the Company’s 3.875% Convertible Senior Notes due 2028
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Enovis CORP entered into Indenture with U.S. Bank Trust Company, National Association valued at $460 million (effective 2023-10-24).
- Action
- entry
- Agreement
- notes offering
- Counterparty
- U.S. Bank Trust Company, National Association
- Value
- $460 million
- Effective
- 2023-10-24
Exact text from the filing
the Company entered into an Indenture, dated October 24, 2023 (the “Indenture”), between the Company and U.S. Bank Trust Company, National Association, as trustee
View on SEC.gov